The methodological objective of Project 3 is to develop statistical and computational models for the analysis of gene expression profiles, and apply them to data. Comparisons of the various existing methodologies (Self-Organizing Maps, Joining Algorithms and other) and selection of the most promising will be first performed using stimulated data sets (Aim 1). An important consideration will be to determine the statistical properties (power, significance) of the different methods, under different assumed patterns of gene expression. The applicable objective will to guide the analysis of gene information gained from Project 1 and 2, suing the SAGE and RAGE techniques (Aim 2). In a first phase this Project will explore the use of existing methods of cluster analysis to determining molecular signature of tumor recurrence based on multiple gene expression patterns, in retrospectively collected tumors with known outcome. The Phase I analyses that will follow using real gene expression data will be of much use in helping to determine the best candidate genes for the preliminary set of signature genes. Subsequently, new methods will be developed to model and estimate other, random trees and Markov chains, will be used. Evaluations, comparisons and testing of new algorithms will be first performed using stimulated gene expression datasets with known and adjustable numbers of variables. Subsequently, data on several hundred tumors obtained using the SAGE and RAGE techniques will be analyzed. A final objective is to develop computational methodologies, which ultimately could be applied via user-friendly software tool packages which will be developed using the software programming support to be provided via the Statistics and Data Management Core B (Aim 4).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA084978-02
Application #
6585976
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-04-16
Project End
2003-03-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
$158,272
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Abel, E L; Boulware, S; Fields, T et al. (2013) Sulforaphane induces phase II detoxication enzymes in mouse skin and prevents mutagenesis induced by a mustard gas analog. Toxicol Appl Pharmacol 266:439-42
Abba, M C; Lacunza, E; Nunez, M I et al. (2009) Rhomboid domain containing 2 (RHBDD2): a novel cancer-related gene over-expressed in breast cancer. Biochim Biophys Acta 1792:988-97
Abba, Martín C; Hu, Yuhui; Levy, Carla C et al. (2009) Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model. Cancer Prev Res (Phila) 2:175-84
Wang, Aijin; Arantes, Stacey; Yan, Leqin et al. (2008) The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis. BMC Cancer 8:268
Abba, Martin C; Sun, Hongxia; Hawkins, Kathleen A et al. (2007) Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 5:881-90
Abba, Martin C; Fabris, Victoria T; Hu, Yuhui et al. (2007) Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. Cancer Res 67:4104-12
Abba, Martin C; Nunez, Maria I; Colussi, Andrea G et al. (2006) GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells. Breast Cancer Res 8:R64
Spyres, Lea; Gaddis, Sally; Bedford, Ella et al. (2005) Quantitative high-throughput measurement of gene expression with sub-zeptomole sensitivity by capillary electrophoresis. Anal Biochem 345:284-95
Abba, Martin C; Hu, Yuhui; Sun, Hongxia et al. (2005) Gene expression signature of estrogen receptor alpha status in breast cancer. BMC Genomics 6:37
Baggerly, Keith A; Deng, Li; Morris, Jeffrey S et al. (2004) Overdispersed logistic regression for SAGE: modelling multiple groups and covariates. BMC Bioinformatics 5:144

Showing the most recent 10 out of 15 publications